close
close

ThreeD Capital Inc. Issues warning report regarding seizure of securities of Quebec Innovative Materials Corp.

Content of the article

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD”) (CSE:IDK / OTCQX:IDKFF), a Canadian venture capital firm focused on opportunistic investments in junior resource and disruptive technology companies, announces that by completing a private placement and acquiring securities through Canadian Securities Exchange (the “Acquisitions”), ThreeD and Sheldon Inwentash (the “Common Entity”) have acquired ownership and control of an aggregate of 1,500,000 common shares (the “Subject Shares”) of Quebec Innovative Materials Corp (the “Company” or “QIMC”) and 1,000,000 common share purchase warrants (the “Subject Warrants” and, together with the Subject Shares, the “Subject Securities”). As a result of the acquisitions, the percentage ownership of ThreeD and the Common Entity increased to over 10% on a partially diluted basis.

Advertisement 2

Article content

Immediately prior to the Acquisitions, ThreeD and the Partner owned and controlled an aggregate of 5,300,000 shares of common stock and 4,000,000 common stock purchase warrants of the Company, representing approximately 5.7% of the total issued and outstanding shares of QIMC common stock (or approximately 9.5% under the partially diluted, assuming the exercise of the warrants held). Of this total, ThreeD held a total of 5,300,000 common shares and 4,000,000 common share purchase warrants, representing approximately 5.7% of the issued and outstanding common shares of QIMC (or approximately 9.5% on a partially diluted basis, assuming exercise warrants held). . The Shareholder did not hold any securities of the Company representing 0.0% of the issued and outstanding common shares on a non-diluted and partially diluted basis.

Advertisement 3

Content of the article

Immediately following the Acquisitions, ThreeD and the Common Actor own and control an aggregate of 6,800,000 shares of common stock and 5,000,000 common stock purchase warrants of the Company, representing approximately 7.3% of all issued and outstanding common shares of QIMC (or approximately 12.0% on a partially diluted basis, assuming the exercise of the warrants held). Of this number, ThreeD held a total of 5,800,000 shares of common stock and 4,000,000 common share purchase warrants, representing approximately 6.2% of the issued and outstanding common shares of QIMC (or approximately 10.0% on a partially diluted basis, assuming exercise of the shares held warrants). The Common Entity held 1,000,000 shares of common stock and 1,000,000 common share purchase warrants, representing 1.1% of the issued and outstanding shares of QIMC common stock (or approximately 2.1% on a partial dilution basis, assuming the exercise of the warrants held).

Advertisement 4

Article content

The Company’s securities held by ThreeD and the Joint Entity are managed for investment purposes. ThreeD and the Common Entities may increase or decrease their investment in the Company at any time or continue to maintain their current position, depending on market conditions or other relevant factors.

The Subject Securities were purchased for an aggregate consideration of USD 45,000, or USD 0.03 per Subject Security.

About ThreeD Capital Inc.

ThreeD is a publicly traded Canadian venture capital firm focused on opportunistic investments in junior resources and disruptive technology companies. ThreeD’s investment strategy is to invest in a range of private and public companies across a variety of sectors worldwide. ThreeD seeks to invest in early-stage, promising companies where it can be a lead investor and, in addition, can provide investors with advisory services and access to the company’s ecosystem.

For further information:
Matthew Davis, CPA
Chief Financial Officer and Corporate Secretary
[email protected]
Phone: 416-941-8900

The Canadian Securities Exchange has not endorsed or disapproved the contents of this press release and is not responsible for its adequacy or accuracy.


Article content